Organization · Other
o2h group
o2h group is an organization that nurtures and invests in emerging life science and technology companies, operating from Cambridge, UK, and Ahmedabad, India. They focus on collaborative innovation in biotech and related fields.
Overview
What o2h group does
What o2h group is
o2h group is an organization that nurtures and invests in emerging life science and technology companies, operating from Cambridge, UK, and Ahmedabad, India. They focus on collaborative innovation in biotech and related fields.
How it participates in the startup ecosystem
The current public profile supports funder and community and event host and publisher capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Other
- Founded
- Founded in 2001
- Approximate age
- About 25 years
- Structured capabilities
- Funder · Community · Event host · Publisher
- Last reviewed
- March 16, 2026
Official channels
Find o2h group elsewhere
Open the official website or a supported primary organization account.
Capability profile
o2h group as a funder
Investment thesis
o2h group focuses on nurturing and investing in emerging life science and technology companies, emphasizing collaborative innovation.
Focus narrative
o2h group invests in early-stage biotech therapeutics and related AI opportunities. Their services include integrated drug discovery, customized software development, and incubation for life science and technology startups. The organization emphasizes collaborative innovation across various sectors, including biotech, small molecules, biologics, digital health, and software.
Value beyond capital
o2h group provides integrated drug discovery services, customized software development, and incubation support to life science and technology startups, fostering innovation and collaboration.
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A · Series B · Series C · Growth Equity
- Regions
- Global · North America · Uk
Availability
- Currently deploying
- Not published
Portfolio and track record
Portfolio context
Notable portfolio companies include: Oxford Drug Design: A biotechnology company focused on developing new antibiotics effective against drug-resistant bacteria. Metrion Biosciences: A contract research organization specializing in ion channel drug discovery. Arecor: A company developing proprietary diabetes products through innovative formulation technology. PhoreMost: A company with a phenotypic screening platform for identifying new therapeutic targets.
Capability profile
o2h group as a community
Community overview
o2h group is an organization focused on nurturing and investing in emerging life science and technology companies. Founded in 2001, it operates from locations in Cambridge, UK, and Ahmedabad, India. The organization is structured into six verticals: o2h ventures, o2h discovery, o2h technology, o2h therapeutics, o2h co-work, and o2h community.
Community focus
o2h group invests in early-stage biotech therapeutics and related AI opportunities. Their services include integrated drug discovery, customized software development, and incubation for life science and technology startups. The organization emphasizes collaborative innovation across various sectors, including biotech, small molecules, biologics, digital health, and software.
Member value
Members benefit from access to funding initiatives, collaborative innovation opportunities, and support for biotech startups through various programs.
Membership
- Pricing models
- free
Format and cadence
- Modality
- hybrid
- Schedule
- rolling-admissions
- Commitment
- light
Availability
- Membership state
- Accepting
Audience and fit
- Audience
- Founders · Investors · Operators
- Benefits
- network-access and mentorship
- Program types
- community
- Selection criteria
- open
- Stages
- Pre-seed · Seed
- Regions
- Global · North America · Uk
Community activity
Events and activity
o2h group organizes and participates in several events, including the Innovation Conference 2026, aimed at fostering collaboration in science and technology, and Biotech Bikers, a networking event supporting the biotech community.
Notable members
Notable portfolio companies include Oxford Drug Design, Metrion Biosciences, Arecor, and PhoreMost. Key team members include Sunil Shah (CEO - o2h Ventures), Prashant Shah (CEO - o2h co-work labs), Andy Morley (Chief Scientific Officer), and Nilesh Dagia (Chief Special Projects Officer).
Capability profile
o2h group as an event host
Event focus
o2h group invests in early-stage biotech therapeutics and related AI opportunities. Their services include integrated drug discovery, customized software development, and incubation for life science and technology startups. The organization emphasizes collaborative innovation across various sectors, including biotech, small molecules, biologics, digital health, and software.
Format narrative
o2h group organizes various events including conferences and networking events aimed at fostering collaboration in the biotech community.
Participant value
Attendees benefit from networking opportunities, insights into the latest innovations in life sciences and technology, and potential collaboration with emerging startups.
Format and cadence
- Event types
- conference and meetup
- Modality
- in-person
- Startups can present
- No
Availability
- Registration state
- Not currently accepting
Audience and fit
- Stages
- Pre-seed · Seed
- Audience
- Founders · Investors · Corporate Innovators
- Regions
- Asia · Global · North America · Uk
Speakers and past editions
Speakers
Notable team members include Sunil Shah, CEO of o2h Ventures; Prashant Shah, CEO of o2h co-work labs; Andy Morley, Chief Scientific Officer; and Nilesh Dagia, Chief Special Projects Officer.
Past editions
Past events include the Innovation Conference 2026 and Biotech Bikers, which focused on networking within the biotech community.
Capability profile
o2h group as a publisher
Editorial focus
o2h group focuses on investing in early-stage biotech therapeutics and related AI opportunities. They provide integrated drug discovery, customized software development, and incubation services for life science and technology startups. The organization promotes collaborative innovation across various sectors, including biotech, small molecules, biologics, digital health, and software.
Audience value
o2h group offers a unique combination of investment, support, and resources for startups in the life sciences and technology sectors, fostering innovation and collaboration.
Format and cadence
- Content formats
- webinar-series
Availability
- Guest pitch state
- Not currently accepting
Audience and focus
- Audience
- Founders · Researchers
- Regions
- Global · In · Uk · United States
Flagship work and coverage
Flagship properties
o2h group publishes 'o2h Chaitime', a webinar series that discusses topics in life sciences and technology.
Common questions
What to know about o2h group
Upseed classifies o2h group under the Other organization type. Its current public profile includes funder, community, event host, and publisher capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 16, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.